Literature DB >> 33424533

Hydrogen Sulfide Overproduction Is Involved in Acute Ischemic Cerebral Injury Under Hyperhomocysteinemia.

Yan Ji1, Yusheng Li1, Zichen Zhao1, Panxing Li1, Yi Xie1.   

Abstract

OBJECTIVES: This study aimed to identify the involvement of hydrogen sulfide overproduction in acute brain injury under ischemia/reperfusion and hyperhomocysteinemia.
METHODS: In vitro and in vivo experiments were conducted to determine: the effect of sodium hydrosulfide treatment on the human neuroblastoma cell line (SH-SY5Y) under conditions of oxygen and glucose deprivation; the changes of hydrogen sulfide levels, inflammatory factors, energetic metabolism, and mitochondrial function in the brain tissue of rats under either ischemia/reperfusion alone or a combination of ischemia/reperfusion and hyperhomocysteinemia; and the potential mechanism underlying the relationship between homocysteine and these changes through the addition of the related inhibitors. Furthermore, experimental technologies, including western blot, enzyme-linked immunosorbent assay, immunofluorescence, reverse transcription polymerase chain reaction, and flow cytometry, were used.
RESULTS: Our study found that high concentration of sodium hydrosulfide treatment aggravated the decrease in mitochondrial membrane potential, the increase in both mitochondrial permeability transition pore and translocation of cytochrome C, as well as the accumulation of reactive oxygen species in oxygen and glucose deprived SH-SY5Y cells. As a result, neurological deficit appeared in rats with ischemia/reperfusion or ischemia/reperfusion and hyperhomocysteinemia, and a higher water content and larger infarction size of cerebral tissue appeared in rats combined ischemia/reperfusion and hyperhomocysteinemia. Furthermore, alterations in hydrogen sulfide production, inflammatory factors, and mitochondria morphology and function were more evident under the combined ischemia/reperfusion and hyperhomocysteinemia. These changes were, however, alleviated by the addition of inhibitors for CBS, CSE, Hcy, H2S, and NF-κB, although at different levels. Finally, we observed a negative relationship between the blockage of: (a) the nuclear factor kappa-B pathway and the levels of cystathionine β-synthase and hydrogen sulfide; and (b) the hydrogen sulfide pathway and the levels of inflammatory factors.
CONCLUSION: Hydrogen sulfide overproduction and reactive inflammatory response are involved in ischemic cerebral injury under hyperhomocysteinemia. Future studies in this direction are warranted to provide a scientific base for targeted medicine development.
Copyright © 2020 Ji, Li, Zhao, Li and Xie.

Entities:  

Keywords:  homocysteine; hydrogen sulfide; inflammatory response; ischemia; mitochondria

Year:  2020        PMID: 33424533      PMCID: PMC7793897          DOI: 10.3389/fnins.2020.582851

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  40 in total

1.  Hydrogen sulfide and carbon monoxide are in synergy with each other in the pathogenesis of recurrent febrile seizures.

Authors:  Ying Han; Jiong Qin; Xingzhi Chang; Zhixian Yang; Junbao Du
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

2.  Release of endogenous amino acids, including homocysteic acid and cysteine sulphinic acid, from rat hippocampal slices evoked by electrical stimulation of Schaffer collateral-commissural fibres.

Authors:  J M Klancnik; M Cuénod; B H Gähwiler; Z P Jiang; K Q Do
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

3.  Free and acid-labile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue.

Authors:  Michael D Levitt; Mohamed Saber Abdel-Rehim; Julie Furne
Journal:  Antioxid Redox Signal       Date:  2011-02-03       Impact factor: 8.401

4.  Determination of sulfide in brain tissue and rumen fluid by ion-interaction reversed-phase high-performance liquid chromatography.

Authors:  J C Savage; D H Gould
Journal:  J Chromatogr       Date:  1990-04-06

Review 5.  Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.

Authors:  R Castro; I Rivera; H J Blom; C Jakobs; I Tavares de Almeida
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

6.  Effects of hydrogen sulfide on cognitive dysfunction and NR2B in rats.

Authors:  Fa-Ping Tu; Jun-Xiang Li; Qiang Li; Ji Wang
Journal:  J Surg Res       Date:  2016-07-05       Impact factor: 2.192

7.  Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis.

Authors:  Yan Ji; Song Tan; Yuming Xu; Avinash Chandra; Changhe Shi; Bo Song; Jie Qin; Yuan Gao
Journal:  Neurology       Date:  2013-09-18       Impact factor: 9.910

Review 8.  The treatment of hyperhomocysteinemia.

Authors:  Bradley A Maron; Joseph Loscalzo
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

9.  Association between percent decline in serum total homocysteine and risk of first stroke.

Authors:  Xiao Huang; Youbao Li; Ping Li; Jianping Li; Huihui Bao; Yan Zhang; Binyan Wang; Ningling Sun; Jiguang Wang; Mingli He; Delu Yin; Genfu Tang; Yundai Chen; Yiming Cui; Yining Huang; Fan Fan Hou; Xianhui Qin; Yong Huo; Xiaoshu Cheng
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

Review 10.  The role of H2S bioavailability in endothelial dysfunction.

Authors:  Rui Wang; Csaba Szabo; Fumito Ichinose; Asif Ahmed; Matthew Whiteman; Andreas Papapetropoulos
Journal:  Trends Pharmacol Sci       Date:  2015-06-09       Impact factor: 14.819

View more
  2 in total

1.  Methionine Diet Evoked Hyperhomocysteinemia Causes Hippocampal Alterations, Metabolomics Plasma Changes and Behavioral Pattern in Wild Type Rats.

Authors:  Maria Kovalska; Eva Baranovicova; Dagmar Kalenska; Anna Tomascova; Marian Adamkov; Libusa Kovalska; Jan Lehotsky
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

2.  The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H2S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia.

Authors:  Bartosz Pomierny; Weronika Krzyżanowska; Jakub Jurczyk; Alicja Skórkowska; Beata Strach; Małgorzata Szafarz; Katarzyna Przejczowska-Pomierny; Roberta Torregrossa; Matthew Whiteman; Monika Marcinkowska; Joanna Pera; Bogusława Budziszewska
Journal:  Int J Mol Sci       Date:  2021-07-22       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.